Brasília – Brazil’s supplementary health sector achieved a historic profit of R$ 12.9 billion in the first half of 2025, marking an increase of approximately 132% compared to the same period in 2024, according to data released by the National Supplementary Health Agency (ANS). This result represents about 6.8% of the sector’s total revenue, which totaled around R$ 190 billion during the semester.

The strong performance was driven by both operational and financial gains. The operating result—revenues minus direct healthcare costs—reached R$ 6.3 billion, a 157% rise year-on-year and the largest figure since 2021. Financial revenues, buoyed by high interest rates, added R$ 6.8 billion to the bottom line, a 55% increase.

Large health plan operators led the gains, but smaller and medium-sized providers also posted significant growth. Meanwhile, the sector continued to see a reduction in sinistrality (claims-to-revenue ratio), falling to 81.1%, the lowest level ever recorded in a first-half period excluding 2020.

Source: O Globo

Would you like a complete analysis on this? Contact us at pharmabrnews@gmail.com